Press


Vedanta Biosciences

Vedanta was founded by PureTech Ventures and a team of world renowned experts in immunology and microbiology. Vedanta is pioneering development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. Vedanta‚Äôs proprietary approach leverages foundational discoveries in the field of mucosal immunology to generate safe and potent treatments that restore intestinal homeostasis acting via mechanisms that are orthogonal to all existing drug classes. By modulating the microbiome with this new class of drugs, we have the opportunity to treat a range of autoimmune and inflammatory diseases in fundamentally new ways and impact the lives of patients.


Team


Contact Us

Ask us anything.

Work with us.